Abstract | BACKGROUND: METHODS: We suggest a therapeutic protocol, for patients with biopsy proven FSGS of native or transplanted kidneys, resistant to steroid and immunosuppressive therapy, based on the association of PE or IA to conventional drug therapy. Daily proteinuria, renal function, serum albumin and circulating level of proteinuric factors (permeability test) will be monitored at regular time intervals during the apheresis cycle, which will be intensive at the beginning (8-10 sessions in 4 weeks) and very gradually discontinued. Results. We will consider satisfactory remission the reduction of proteinuria below 1 g/day, improvement of renal function, normalization of serum albumin level (> 3.5 g/dl). Partial remission will be considered: proteinuria below 3 g/day, stable renal function, serum albumin level between 3 and 3.5 g/dl. Permeability test, if positive at baseline examination, should be negative after apheresis. CONCLUSIONS: The primary endpoint of our protocol is: lasting remission (satisfactory or partial) after the apheresis suspension. Secondary endpoints are: maintained remission with continuing apheresis sessions, correlation between permeability activity and disease activity, identification of responders and non responders patients on the basis of positive permeability test.
|
Authors | L Moriconi, S Passalacqua, R Pretagostini, G Battaglia, G Russo, T De Palo, P Rindi, R Puccini, V Batini, M Carraro, L Faccini, M Artero, C Zennaro, R Cristofani |
Journal | Journal of nephrology
(J Nephrol)
2000 Sep-Oct
Vol. 13
Issue 5
Pg. 347-51
ISSN: 1121-8428 [Print] Italy |
PMID | 11063138
(Publication Type: Comparative Study, Journal Article)
|
Topics |
- Adolescent
- Adult
- Child
- Child, Preschool
- Clinical Protocols
- Female
- Follow-Up Studies
- Glomerulosclerosis, Focal Segmental
(diagnosis, surgery, therapy)
- Graft Survival
- Humans
- Kidney Function Tests
- Kidney Transplantation
- Male
- Middle Aged
- Plasmapheresis
(methods)
- Prospective Studies
- Sampling Studies
- Treatment Outcome
|